Innovent's Pecondle, a recombinant anti-interleukin-23p19 subunit, receives China NMPA approval to treat moderate-to-severe plaque psoriasis: San Francisco Monday, December 1, 202 ...

PECONDLE® (picankibart injection) has received approval from China's National Medical Products Administration (NMPA) for the treatment of ...

Innovent Biologics has picked up approval in China for Pecondle, its anti-IL-23p19 antibody, as a treatment for ...

China's National Medical Products Administration (NMPA) has approved Innovent Biologics’ Pecondle (picankibart injection), a ...

FOR Dar es Salaam resident Frank Latamani, the chronic skin condition known as Psoriasis has become not only a painful ordeal ...

The blogger Howard Chang explores the latest advancements bringing hope for a psoriasis cure, some of which were presented at a community event.

Psoriasis can affect the fingers, knuckles, nails, palms, and soles. Here’s what this psoriasis looks like and how to relieve symptoms like itch.

In the video, Dr. Nicola J. Gullick, a Consultant Rheumatologist in Coventry and one of the investigators on the PRO-SPIRIT ...

Vanda advances with strong Fanapt growth, late-stage catalysts, GLP-1 potential, higher investment and solid balance sheet ...

Oruka Therapeutics recently reported its third quarter 2025 results, including a net loss of US$30.28 million, and completed a major US$180 million PIPE financing to extend its cash runway beyond key ...

Then I started to hear even more about it when The Patch zeroed in on two of New Jersey’s biggest pharmaceutical giants, Bristol Myers Squibb and Merck. In that article, they cited the popular drugs ...

Johnson & Johnson (JNJ) 7th Annual Wolfe Research Healthcare Conference November 17, 2025 10:40 AM ESTCompany ParticipantsCandice Long - Worldwide ...